quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 28, 2026

Autohome Inc. Announces Unaudited First Quarter 2026 Financial Results

View original at finance.yahoo.com
Autohome Inc. Announces Unaudited First Quarter 2026 Financial Results BEIJING, May 28, 2026 /PRNewswire/ -- Autohome Inc…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Autohome continued to grow its user base steadily by strengthening premium content development and expanding its new media matrix.

    60% confidence
  • The RMB to USD conversion rate used is US$1.00 to RMB6.8980, the noon buying rate on March 31, 2026, as certified by the Federal Reserve Bank of New York.

    60% confidence
  • The average number of Autohome's mobile daily active users in March 2026 reached a record high of over 80 million, up 4.9% year-over-year, according to QuestMobile.

    60% confidence
  • Autohome is transforming its platform from an automotive information media into a comprehensive automotive service ecosystem.

    60% confidence
  • Autohome is advancing a dual-circulation model encompassing both domestic and international markets, representing a new development phase.

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Autohome Inc. Announces Unaudited First Quarter 2026 Financial Results — Source | Via News | pt.VIA.NEWS